Non-invasive risk stratification in NAFLD/NASH patients for screening esophagogastroduodenoscopy

J. Romano et al. (Medical University of South Carolina, Charleston, USA) evaluated whether these non-invasive markers and/or any other clinical parameters may be used to identify patients with liver cirrhosis who are likely to have large esophageal varices, and therefore would benefit most from screening esophagogastroduodenoscopy.